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BubR1 is essential for the mitotic checkpoint that prevents
aneuploidy in cellular progeny by triggering anaphase delay in
response to kinetochores incorrectly/not attached to themitotic
spindle. Here, we define the molecular architecture of the func-
tionally significant N-terminal region of human BubR1 and
present the 1.8 A˚ crystal structure of its tetratricopeptide repeat
(TPR) domain. The structure reveals divergence from the clas-
sical TPR fold and is highly similar to the TPR domain of bud-
ding yeast Bub1. Shared distinctive features include a disor-
dered loop insertion, a 310-helix, a tight turn involving glycine
positive angles, and noncanonical packing of and between the
TPR motifs. We also define the molecular determinants of the
interaction between BubR1 and kinetochore protein Blinkin.
We identify a shallow groove on the concave surface of the
BubR1TPRdomain that formsmultiple discrete andpotentially
cooperative interactions with Blinkin. Finally, we present evi-
dence for a direct interaction between BubR1 and Bub1 medi-
ated by regions C-terminal to their TPR domains. This interac-
tion provides a mechanism for Bub1-dependent kinetochore
recruitment of BubR1. We thus present novel molecular
insights into the structure of BubR1 and its interactions at the
kinetochore-microtubule interface. Our studies pave the way
for future structure-directed engineering aimed at dissecting
the roles of kinetochore-bound and other pools of BubR1 in
vivo.
The spindle assembly checkpoint (SAC2; also referred to as
the mitotic checkpoint) performs the critical role of triggering
anaphase delay in response to chromosomes incorrectly/not
attached to the mitotic spindle (1). This prevents aneuploidy
and associated genetic instability that result from anaphase
commencing prior to the proper bi-orientation of replicated
chromosomes. At the molecular level, the SAC inhibits the E3
ubiquitin ligase activity of the anaphase promoting complex/
cyclosome (APC/C) (2). This prevents the ubiquitination and
degradation of anaphase inhibitors, Securin and cyclin B1 (3).
Securin inhibits the protease that would otherwise cleave the
Cohesin complex holding sister chromatids together (4),
whereas cyclin B1 regulates the activity of Cdk1 (cyclin-depen-
dent kinase 1). The multidomain kinase BubR1 (budding unin-
hibited by benomyl related-1) is an essential component of the
SAC of higher eukaryotes (5, 6). BubR1 mutations and/or mis-
regulation have been detected in human cancers (7) and the
related disease of mosaic variegated aneuploidy (8, 9). Reduced
levels of BubR1 in mice also lead to increased tumor incidence
and accelerated tumor progression (10–13). BubR1 has also
recently been shown to be important for the segregation of
acentric chromosome fragments that lack a kinetochore (14)
and for oocyte meiotic transitions (15).
BubR1 inhibits APC/C activity during metaphase as part of
the mitotic checkpoint complex (MCC) (Fig. 1A) (16). The
MCC is composed of BubR1, Bub3, Mad2 (mitotic arrest defi-
cient 2), andCdc20 (cell division cycle 20). Cdc20 is an essential
APC/C co-factor that mediates the recognition of substrates
that harbor short sequence motifs such as KEN boxes (consec-
utive lysine, glutamate, and asparagine residues) (17). The for-
mation of the MCC inhibits APC/C ubiquitin ligase activity by
abrogating Cdc20 co-factor function (16). Within the MCC,
Cdc20 directly binds a conformer of Mad2 and the constitutive
BubR1-Bub3 complex. These interactions are independently
capable of APC/C-Cdc20 inhibition, although highest potency
inhibition is achieved through simultaneous binding, likely
because of Mad2 promotion of the BubR1-Cdc20 interaction
(18–20). Two complementary molecular mechanisms have
been proposed for APC/C-Cdc20 inhibition by BubR1-Bub3
andMad2. First is an inhibitory conformational shift of Cdc20,
in which single particle electron microscopy reveals distinct
orientations ofCdc20when it is bound to theAPC/Calone or as
part of theMCC (21). It is possible that one of these orientations
induces Cdc20 ubiquitin-mediated degradation (22). Second is
competitive binding of BubR1 to substrate-binding sites of
APC/C-Cdc20; BubR1 contains two conserved KEN boxes
(human residues 26–28 and 304–306) that are essential for
Cdc20 binding and cell viability and act to competitively block
substrate binding to APC/C-Cdc20 (23, 24). This function of
BubR1 is dependent uponPCAF (p300/CBP-associated factor)-
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dependent acetylation at Lys250, which prevents BubR1 ubiq-
uitin-mediated degradation (25).
In addition to a role in the MCC, BubR1 is enriched and
exchanged at kinetochores incorrectly/not attached to the
mitotic spindle during metaphase (Fig. 1B) (26). Kinetochores
are large proteinaceous complexes that form on centromeric
chromatin and mediate microtubule binding (27). BubR1 ki-
netochore enrichment is dependent on Bub1 and Bub3 (28, 29)
and is required to sustain a SAC arrest, as well as for stable
kinetochore-microtubule interactions (23). The mechanistic
links between BubR1 kinetochore enrichment and these activ-
ities, however, have yet to be deciphered. Regulated cycling
between kinetochore-bound andMCC pools of BubR1, similar
to that observed forMad2, is thought not to occur (19), whereas
BubR1 interaction with the kinetochore protein Blinkin (Bub-
linking) and microtubule binding, molecular motor CENP-E
(centromeric protein E) may be important (30–32). Blinkin is
vital for the formation of wild type kinetochore-microtubule
interactions and interacts with an N-terminal -helical region
of BubR1 (32, 33); CENP-E regulates BubR1 kinase activity and
localizes to the kinetochore in a BubR1-dependentmanner (30,
31). Post-translational modification of BubR1 at the kineto-
chore is also likely to play a role (34). These links remain as
conjecture as such mechanistic insight requires a detailed
molecular understanding of BubR1. Molecular detail of BubR1
is not available as attempts to produce stable protein for high
resolution structural studies have been hampered by BubR1
susceptibility to proteolysis, rendering such studies thus far
unsuccessful (35, 36).
Insight into the structure of BubR1 can be gained by compar-
ison with Bub1, which shows a similar overall domain organi-
zation and shares ligandsBlinkin andBub3 (Fig. 1C) (32, 36, 37).
Both proteins contain an N-terminal -helical region that
mediates Blinkin binding (32), a central disordered region con-
taining a shortmotif for Bub3 binding (36, 37), and aC-terminal
serine/threonine kinase domain that is absent in lower eukary-
otic BubR1 orthologues such as yeast Mad3 (38). The crystal
structure of the N-terminal -helical region of budding yeast
Bub1 has been solved and reveals a divergent tetratricopeptide
repeat (TPR) domain (39). Based on sequence analysis and bio-
physical studies, the N-terminal -helical region of BubR1 is
also expected to adopt a TPR fold (40). In this study, we define
the molecular architecture of the N-terminal region of human
BubR1 and present the 1.8 Å crystal structure of human BubR1
residues 48–237 (BubR1(48–237)). These residues include a
triple tandem arrangement of the TPR motif with predicted
similarity to that found in budding yeast Bub1. We thus define
the structural platform that mediates BubR1 interaction with
Cdc20 in the MCC and Blinkin at the kinetochore. We further
examine the molecular determinants of the interaction
between BubR1 and Blinkin, revealing the presence of multiple
discrete and potentially cooperative interactions along a groove
of BubR1. Finally, we identify an interaction between BubR1
and Bub1 mediated by regions C-terminal to their TPR
domains. These data are invaluable for future studies aimed at
defining the precise roles of kinetochore-bound and MCC
pools of BubR1 in the SAC in vivo.
EXPERIMENTAL PROCEDURES
Yeast Two-hybrid Analysis—Human gene fragments
encoding for BubR1 full-length (BubR1fl), residues 1–237
(BubR1(1–237)) and residues 238–1050 (BubR1(238–1050))
(GenBankTM accession number AAD11941), Bub1 full-length
(Bub1fl), residues 1–189 (Bub1(1–189)) and residues
189–1085 (Bub1(189–1085)) (GenBankTM accession number
AAC06259), Blinkin residues 1–728 (Blinkin(1–728))
(GenBankTM accession number AAM45143), and Bub3 full-
length (Bub3fl) (GenBankTM accession number AAC06258)
were cloned into pGBT9 and pGAD424 (Clontech). BubR1fl
point mutants (P119A, L126A, R130A, S157A, E161A, and
R165A)were created by overlapping primer extensionmethods
and cloned to pGBT9.
Yeast two-hybrid protocols were based on theMatchmaker 3
yeast two-hybrid system (Clontech), where the rate of yeast
growth, the number of resultant colonies, and the intensity of
X-gal reactions are directly related to the level of reporter gene
activation (41). Using a polyethylene glycol/single-stranded
DNA/LiAc procedure, pGBT9 vectors were transformed into
the Y187 strain, and pGAD424 vectors were transformed into
the AH109 strain. For mating, single colonies of Y187[pGTB9-
bait] and AH109[pGAD424-target] were resuspended in 0.5ml
of 2 YPDA and incubated at 30 °C, 50 rpm for 24 h. Cultures
were diluted 1 in 10 with 0.5 YPDA and 100 l plated on
SD/Leu/Trp (double dropout) and SD/Ade/His/Leu/
Trp (quadruple dropout) plates. Plates were incubated at
30 °C for 2, 3, or 5 days.Matingswith BubR1flmutantswere also
grown with 0–15 mM 3-amino-1,2,4-triazole (3-AT; Sigma) on
the quadruple dropout plates. Colonies were lifted onto filters
(Whatman No. 5, 70 mm), lysed by two cycles of freeze-thaw
and incubated in 100 mM sodium phosphate, pH 7.0, 10 mM
KCl, 1 mMMgSO4, 0.3% (v/v) -mercaptoethanol containing 1
mg/ml X-gal (Promega) at 30 °C for 5 h. Shown filters are rep-
resentative of at least three replicates performed with inde-
pendent yeast transformants.
For time course and 3-AT analysis, densitometry was per-
formed by measuring mean pixel intensities of color-in-
verted scanned filters. The intensity of a relevant negative
control, such as pGBT9-bait  pGAD424-empty, was sub-
tracted from each value. “Relative intensity of interaction
with Blinkin(1–728)” refers to (pGBT9-BubR1fl-mutant 
pGAD424-Blinkin(1–728) at a particular day or 3-AT concen-
tration) divided by ((pGBT9-BubR1fl-mutant  pGAD424-
Blinkin(1–728)) at day 5 or with 0mM 3-AT); likewise, “relative
intensity of interaction with Bub3fl refers to ((pGBT9-BubR1fl-
mutant  pGAD424-Bub3fl) at a particular day or 3-AT con-
centration) divided by ((pGBT9-BubR1fl-mutant pGAD424-
Bub3fl) at day 5 or with 0 mM 3-AT).
Protein Expression and Purification—Human gene frag-
ments encoding for BubR1 residues 1–230 (BubR1(1–230)) and
1–280 (BubR1(1–280)) were cloned into pGEX-6P-1 (GE
Healthcare) with a PCR-introduced C-terminal His6 tag,
whereas BubR1 residues 39–230 (BubR1(39–230)) and
48–237 (BubR1(48–237)) were cloned into pHAT4 (42).
All proteins were expressed in Escherichia coli BL21(DE3)
grown in 2 YT (Sigma) with 100 g/ml ampicillin by induc-
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tion with 0.4 mM isopropyl-D-thiogalactopyranoside for 3 h at
37 °C. Cells were suspended in 20mMTris-HCl, pH8.0, 300mM
NaCl, 1 mM 1,4-dithiothreitol with protease inhibitor mixture
(Roche Applied Science) and lysed using an EmulsiFlex-C5
(Avestin). The soluble fraction was obtained by centrifugation
at 15,000  g at 4 °C for 30 min. Glutathione S-transferase
fusions (BubR1(1–230) and BubR1(1–280)) and histidine tag
fusions (BubR1(39–230) and BubR1(48–237)) were then puri-
fied by standard affinity chromatography and cleaved by over-
night incubation with PreScissionTM (GE Healthcare) or
tobacco etch virus protease, respectively. Protease, tag, and
uncleaved fusion were removed by a second affinity chroma-
tography step. BubR1(1–230) and BubR1(1–280) were further
purified with Ni2- nitrilotriacetic acid affinity chromatogra-
phy, whereas BubR1(39–230) and BubR1(48–237) were fur-
ther purified by ion exchange at pH 9.0 using a Resource Q
column (GE Healthcare). All proteins were polished with size
exclusion chromatography. Proteins were biochemically and
biophysically characterized as described in the supplemen-
tal material.
Crystallization and Data Collection—BubR1(48–237) was
concentrated to 9 mg/ml following size exclusion chromatog-
raphy in 20 mM CHES, pH 9.0, 200 mM NaCl, 1 mM 1,4-dithio-
threitol. Reducing agent tris(2-carboxyethyl)phosphine, pH
8.0, was then added at a final concentration of 1 mM and the
sample used for crystallization. The best crystals were grown at
15 °C using the sitting drop vapor diffusionmethod with 140l
of reservoir solution (22 g/100 ml of PEG 8000, 200 mM Tris-
HCl, pH 8.0, 10 mM praseodymium(III) acetate) and a 200-nl
drop (equal volume of protein and reservoir solution) in a
96-well format (Greiner). The crystals were cryoprotected by
addition of 20% (v/v) ethylene glycol (soaked for 1 min)
and frozen in liquid nitrogen for data collection at 100 K.
Data were collected for two crystals at a wavelength of 1.06 Å
at beam I03, Diamond Synchrotron Light Source, Oxford,
UK, and processed using MOSFLM and SCALA from the
CCP4 suite (43, 44).
Structure Determination and Refinement—The structure of
BubR1(48–237) was solved by single wavelength anomalous
dispersion using praseodymium ions from the crystallization
solution, found stably in the crystal lattice. Using data collected
from crystal 1 (anomalous completeness of 100% and anoma-
lous redundancy of 11.1), two praseodymium ions were found
and refined using autoSHARP (45). The final figure ofmerit was
0.82; the phasing power was 1.75, and the Rcullis was 0.66. Fol-
lowing density modification with 43.2% solvent content, these
phases were used to calculate an initial map used for automated
model building with ARP/wARP (46). Iterative cycles of model
building and refinement were then carried out in COOT (47)
and REFMAC 5 (48) using data collected from crystal 2, includ-
ing a single cycle of Translation, Liberation, and Screw refine-
ment with two groups (residues 57–114 and 115–220) identi-
fied by the TLMSD server (49). During refinement, 5% of
reflections were kept aside for evaluation of Rfree. Residues
48–56, 92–95, and 221–237 are absent in the final model.
PyMOL (DeLano Scientific) was used to create images.
RESULTS
BubR1 Directly Interacts with Blinkin and Bub1—A major
challenge in developing a molecular understanding of the SAC
is establishing the structural basis of BubR1 kinetochore
recruitment and APC/C-Cdc20 inhibition. We first set out to
confirm the reported interaction between the N-terminal
region of BubR1 and Blinkin and to investigate the interac-
tions between BubR1 and functionally related proteins Bub1
and Bub3. Human sequences of full-length BubR1 (BubR1fl),
BubR1(1–237), BubR1(238–1050), Bub1fl, Bub1(1–189),
Bub1(189–1085), Blinkin(1–728), and Bub3fl were fused to
GAL4 DNA-binding domains and GAL4 activator domains.
Interactions were tested through the highly stringent Match-
maker 3 yeast two-hybrid system in which positive interactions
were determined by independent activation of three reporter
genes (HIS, ADE, and lacZ). In this system, the rate of yeast
growth, the number of resultant colonies, and the intensity of
X-gal reactions are directly related to the underlying level of
reporter gene activation (41). BubR1(1–237) was found to
interact with Blinkin(1–728) in a manner equivalent to that of
full-length protein (Fig. 1D), confirming that Blinkin(1–728)
forms contacts with the N-terminal region of BubR1. In con-
trast, interaction with Bub3fl was detected only for full-length
BubR1 (Fig. 1D), consistent with the known Bub3-binding site
downstream of the N-terminal region (36, 37). Related protein
Bub1 showed a similar pattern of binding to Blinkin(1–728)
through its N-terminal region and Bub3fl through a down-
stream region (Fig. 1D). We were regrettably unable to test
interactions using pGBT9-Blinkin(1–728) and pGBT9-Bub1fl
vectors due to insurmountable technical difficulties of autoac-
tivation and toxicity, respectively. We thus conclude that the
BubR1 N-terminal region interacts with Blinkin, whereas a
more C-terminal region interacts with Bub3.
The yeast two-hybrid experiments also indicate an interac-
tion between BubR1 and Bub1 (Fig. 1,D and E). The interaction
does not rely on the N-terminal region of Bub1 or BubR1, is
retained upon deletion of the N-terminal regions, and specifi-
cally allows formation of a BubR1-Bub1 heterodimer but not a
BubR1-BubR1 homodimer. Failure to detect a heterodimeric
complex of BubR1(1–237) and Bub1(1–189) is consistent with
in vitro analytical size exclusion chromatography and chemical
cross-linking analysis with recombinant proteins (data not
shown). We thus conclude that BubR1 and Bub1 undergo het-
erodimerization through the interaction of distinct sequences
in their C-terminal regions (Fig. 1, D and E). Our findings con-
flict with previously published yeast two-hybrid data suggesting
both homo- and heterodimerization of BubR1 and Bub1 (32).
We account for this through our observation that the BubR1fl
GAL4DNA-binding domain fusion exhibits a low level of auto-
activation that hampers investigations using only the lacZ
reporter gene (supplemental Fig. S1) but is completely elimi-
nated by the three independent reporter genes (HIS, ADE, and
lacZ) employed in this study. The formation of a BubR1-Bub1
complex is consistent with reports that BubR1 kinetochore
recruitment is dependent on Bub1when the capacity of Blinkin
to bind BubR1 is abrogated in vivo (32).
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Molecular Architecture of the BubR1 N-terminal Region—We
next investigated the molecular architecture of the BubR1
N-terminal region. To explore the presence of domain struc-
ture, recombinant human BubR1(1–280) was subjected to lim-
ited proteolysis using trypsin, which specifically cleaves peptide
chains C-terminal to Lys andArg residues. Despite Lys andArg
residues being distributed throughout BubR1(1–280), this
identified protease-resistant fragments of18 and 20 kDa (Fig.
2A). Edman degradation and tandem mass spectrometry pep-
tide fragmentation analyses subsequently showed that these
fragments contain residues Ile37–Arg199 or Arg202 and Ile37–
Arg224, respectively, suggesting the presence of a folded domain
within these limits. The trypsin cleavage site immediately
downstream of Arg36 is Lys59, indicating that the N-terminal
boundary of this folded domain lies between Ile37 and Lys59.
This is supported by our observation that degradation prod-
ucts of BubR1(1–230) formed during purification are N-ter-
minally truncated at residues Arg33, Ser39, Glu42, Gly43,
Ala44, and Ala46 (shown by Edman degradation; data not
shown). Interestingly, the N-terminal fragment cleaved from
BubR1 is conserved in BubR1 but not Bub1 orthologues and
contains one of the conserved KEN box motifs essential for
interaction with Cdc20 (Fig. 3A) (23). Similarly, the presence
of protease-resistant fragments that undergo C-terminal
cleavage at Arg199/202 or Arg224 suggests a mobile C-terminal
region. One frequently sampled conformation of this region
must constrain residues Arg199–Arg224 as cleavage at the
intervening trypsin site Lys210 was not observed. Our analy-
sis thus predicts a molecular architecture for the N-terminal
region of BubR1 in which a folded domain is preceded by an
N-terminal extension of 36–58 amino acids that is con-
nected by a flexible linker.
FIGURE1.Architectureand interactionsofBubproteins.AandB, BubR1 interactionsaway from(A) andat (B) thekinetochoreduringSACactivation. The stars
represent kinase domains, and the gray circles represent different APC/C subunits.C, domain organization of humanBubR1, yeastMad3, andhumanBub1. The
proteins contain a conserved N-terminal region (black), a central disordered region incorporating the Bub3-binding site (light gray), and numerous KEN boxes
(dotted line). The C-terminal kinase domain (gray) and Blinkin-binding site (solid line) of the human proteins are also shown. D and E, BubR1 interacts with
Blinkin, Bub1, andBub3 in a yeast two-hybrid assay. Strains Y187(pGBT9-bait) andAH109(pGAD424-target)weremated andX-gal filter lift assays performedon
colonies grown on SD/Ade/His/Leu/Trp plates. Colony growth requires the activation of ADE and HIS reporter genes, and the blue-producing X-gal
reaction requires the activation of the lacZ reporter gene. Data for pGBT9-Blinkin(1–728) and pGBT9-Bub1fl vectors are not shown due to insurmountable
technical difficulties of autoactivation and toxicity, respectively.
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To probe further the molecular architecture of the BubR1
N-terminal region, biophysical analysis was performed on a
construct in which the putative N-terminal extension was
deleted, BubR1(48–237). The N-terminal boundary of this
construct was based on secondary structure prediction and the
Ile37–Lys59 range defined by limited proteolysis. Similarly, the
C-terminal boundary was selected to be outside of the folded
domain between predicted -helices such that the fold is
expected be retained. Sedimentation velocity analysis of
BubR1(48–237) revealed the presence of a single species of
molecular mass 21.6 kDa (theoretical molecular mass of 22.4
kDa) with a frictional coefficient of 1.38 (Fig. 2B), suggesting a
monomer with an elongated, asymmetrical shape. The mono-
meric status was consistent with chemical cross-linking (data
not shown) and is in keeping with the yeast two-hybrid finding
that BubR1 is incapable of homodimerization (Fig. 1D). An
extended conformation is also supported by the large Dmax of
67  0.11 Å measured with small angle x-ray scattering (Fig.
2C) and analytical size exclusion chromatography in which
BubR1(48–237) eluted as a single species at a volume corre-
sponding to 1.6 times the mass predicted for a compact, glob-
ular monomer (Fig. 2D). Interestingly, on the same Superdex
column, constructs inwhich theN-terminal extensionwas pro-
gressively re-introduced, BubR1(39–230) and BubR1(1–230),
showed elution volumes corresponding to 1.8 and 2.0 times the
mass predicted for compact, globular monomers, respectively.
Circular dichroism of BubR1(48–237) further revealed a pre-
dominantly -helical content, with spectra minima at 208 and
222 nm (Fig. 2E). Together, these biophysical analyses lead to a
model in which the BubR1 N-terminal region contains an
-helical domain with a protruding N-terminal extension that
is connected by a flexible linker. Importantly, these data also
demonstrate that removal of theN-terminal extension does not
compromise the fold, thus allowing the production of a stable
construct of the BubR1 N-terminal region suitable for struc-
tural analysis in vitro.
FIGURE 2. Biochemical and biophysical characterization of the BubR1 N-terminal region. A, limited proteolysis of BubR1(1–280) identified protease-
resistant fragments of18 and 20 kDa. These fragments encompass residues Ile37–Arg199 or Arg202 and Ile37–Arg224, respectively. B, sedimentation velocity
analysis of BubR1(48–237) reveals it tobe anasymmetricalmonomer. Using absorbancedata (top), the sedimentation coefficient distribution c(S) (bottom)was
calculatedusing SEDFIT tominimize residuals (middle) andwith a rootmean squaredeviation (r.m.s.d.) of less than0.01. The resultant frictional coefficient (f/f0),
sedimentation coefficient (S), and molecular weight (MW) are shown. C, small angle x-ray scattering of BubR1(48–237) measures a Dmax of 67  0.11 Å,
indicating an elongated shape. The intra-particle distance distribution function p(r) was calculated using GNOM. D, analytical size exclusion chromatography
of BubR1 proteins shows that the calculated (cal.) to predicted (pred.) molecular weight ratio increases as more of the N-terminal of BubR1 is included.mAU,
milli-absorbance units. E, far-UV circular dichroism spectra of BubR1(48–237) reveal a predominantly -helical structure.
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Overall Structure of the BubR1 N-terminal Region—The
BubR1N-terminal region 1.8Å crystal structurewas solved using
single wavelength anomalous dispersion of BubR1(48–237) crys-
tals grown in the presence of 10 mM praseodymium(III) acetate
(Table 1). High quality electron densitywas present for residues
57–220 (supplemental Fig. S2) excluding residues 92–95,which
likely constitute a disordered loop. The structure is composed
of eight -helices arranged in an anti-parallel fashion reminis-
cent of a TPR domain (Fig. 3, A and C) (50). The central six
-helices fold into three sequential helix-loop-helix units
(TPR1–3), with their -helices forming concave inner and
outer surfaces. Each of the helix-loop-helix units resembles a
single TPR motif, a well known motif in which the consensus
sequence contains small hydrophobic residues at positions 8,
20, and 27, large hydrophobic residues at positions 4, 7, 11, and
24, and an -helix-breaking residue, typically a proline, at posi-
tion 32 (Fig. 5A) (50–52). The three TPR units are packed
together such that “A” -helices form the inner surface and “B”
-helices form the outer surface, and the entire structure has a
subtle right-handed super-helical twist. Important to this
arrangement is a tight turn involving positive angles of Gly146
and Gly148 in the conserved GIG motif connecting TPR2 and
TPR3.
The BubR1 structure also contains a short N-terminal -he-
lix connected by a kinked loop and an extended C-terminal
-helix that mimics an A-type helix but protrudes greater than
20 Å from the molecule (Fig. 3, A and C). These -helices are
unlikely to form additional TPR motifs in the full-length pro-
tein given the hydrophilic nature of their outer edges. The
extended C-terminal -helix resembles a capping -helix as
observed in numerousTPRdomains (50). The protrusion of the
C-terminal -helix, however, may be an artifact of crystal pack-
ing as glutamate residues in this region (Glu212, Glu214, Glu215,
andGlu218) coordinate two praseodymium(III) ions in the crys-
FIGURE 3. 1.8 Å crystal structure of the BubR1N-terminal domain reveals a TPR fold. A, sequence alignment of the N-terminal region of Bub proteins. The
alignment was created with ClustalX2 and visualized with ESPRIPT. Sequences shown are from Homo sapiens (Hs), Mus musculus (Mm), and Saccharomyces
cerevisiae (Sc). Secondary structure elements are shown and colored as in C. Many residues are conserved (black box) or semi-conserved/similar (gray).
B, coordination of Pr(III) in the BubR1 crystals. The crystal contains two Pr(III) (black spheres) per BubR1 protomer coordinated by twowaters (small spheres), an
acetate (black), and seven residues from three protomers (sticks). C, orthogonal views of the BubR1 TPR domain.
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tal (Fig. 3B). The lower average B-factor of the protruding
region (30.8 for residues 203–220 compared with 37.5 for resi-
dues 57–202) reinforces its constraint in the crystal lattice. In
solution or in the context of the full-length protein, this
sequence may become disordered or may contribute to novel
structure. Such a scenario has been reported for protein phos-
phatase 5 (PP5), a TPR domain protein in which an extended
C-terminal -helix unwinds to form a disordered loop in the
full-length protein (53, 54). As also suggested by the aforemen-
tioned limited proteolysis data, the extended conformation of
the C-terminal -helix is likely to be one of many conforma-
tions sampled in solution. It is not known if this extended con-
formation is relevant to a physiological interaction.
Comparison of BubR1 and Bub1 TPR Domains—To confirm
the TPR nature of the BubR1 N-terminal region, the DALI
server was employed (55). Such confirmation is important as
differences between all -helical repeat domains such as HEAT
repeats, Armadillo repeats, and clathrin heavy chain repeats
can be subtle and difficult to predict (56). The analysis revealed
the most similar structure to be the budding yeast Bub1 TPR
domain, with moderate similarity to canonical TPR domains
such as defining member PP5 and an engineered three-repeat
TPR domain (Fig. 4A). Similar to the BubR1 structure, the
Bub1, PP5, and engineered TPR domains each contain three
TPR motifs and, in the case of PP5 and the engineered TPR
domains, a C-terminal capping -helix. As such, these results
attest to a TPR fold with noncanonical features shared between
the BubR1 and Bub1 TPR domains (Fig. 4B). A TPR fold similar
to the Bub1 TPR domain was predicted for the BubR1N-termi-
nal region. Key features common to BubR1 and Bub1 but not
other TPR domains include a disordered loop within TPR1, a
short, approximately perpendicular 310-helix connecting TPR1
and TPR2, a tight turn involving positive  angles between
TPR2 and TPR3, and noncanonical packing of and between
TPR motifs (see below). These features define the “Bub
protein” TPR domain that shows diversification of the classical
TPR fold. The conservation of these defining features further
suggests that they are important for the structural integrity
and/or specific functionality.
The BubR1 and Bub1 TPR domains, however, do adopt dis-
tinct conformations peripheral to the three TPR motifs (Fig.
4B). Namely, a disordered region, a short -helix, and a kinked
loop at the N terminus of the BubR1 TPR domain are replaced
by an -helix, a 310-helix, and a short loop at the N terminus of
the Bub1 TPR domain. Although potentially due to crystal
packing, these distinct conformations may reflect species-spe-
cific differences, i.e. the Bub1 conformation may be unique to
yeast Bub1 as sequence conservation between Bub1 ortho-
logues is moderate in this region (Fig. 3A). Alternatively, the
comparatively flexible conformation of BubR1may be required
for the BubR1-specific function of presenting the upstream
KENbox toAPC/C-Cdc20. The BubR1 andBub1TPRdomains
also have different C-terminal regions (Fig. 4B). The protruding
segment of the C-terminal -helix and immediately adjacent
disordered region of the BubR1 TPR domain are replaced by an
unfolded segment that connects to two short -helices that lie
across the outer concave surface of the TPRmotifs of the Bub1
TPR domain. As discussed previously, these distinct conforma-
tions may be an artifact of crystal packing and/or protein trun-
cation. Themoderate sequence conservation of this region also
raises the possibility of species-specific differences (Fig. 3A).
A final distinction between the BubR1 and Bub1 TPR
domains relates to quaternary structure, with BubR1 being a
monomer (Fig. 2B) and Bub1 a dimer (Fig. 4C) in both solution
TABLE 1
Data collection and refinement statistics
Crystal 1 is for SAD, and Crystal 2 is for refinement.
Crystal 1 Crystal 2
Data collection
Space group P3221 P3221
Cell dimensions
a, b, c 62.67, 62.76, 90.29 Å 62.67, 62.76, 90.29 Å
, ,  90, 90, 120° 90, 90, 120°
Resolution 2.0 Å (2.1-2.0 Å)a 1.8 Å (1.9-1.8 Å)a
Rmerge 11.2% (42.0%) 10.7% (51.0%)
I/I 23.9 (6.6) 21.0 (4.0)
Completeness (%) 100 (100) 99.9 (100)
Redundancy 20.8 (21.3) 15.6 (15.8)
Refinement
Resolution (Å) 54.4-1.8
No. reflections (Rfree) 18643 (1005)
Rwork/Rfree 0.222/0.259
Protein atoms 1358
Water atoms 117
Ligand/Ion atoms 14
(2 Pr, 1 acetate, 2 ethylene glycol)
B-factors (Å2)
Protein 36.8
Ligand/Ion 32.5
Water 41.2
Root mean square deviations
Bond lengths 0.016 Å
Bond angles 1.685°
Residues in structure Gln57–Gln91, Ser96–Ser220
Residues in preferred/allowed - region of Ramachandran plot 96.15/3.85%
Protein Data Bank code 2WVI
a Values in parentheses are for highest resolution shell.
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and crystalline states. This difference occurs as Bub1 dimeriza-
tion is mediated by salt bridges involving residues whose
homologous partners in BubR1 are mostly neutral (Fig. 3A and
Fig. 4, C and D). This lack of conservation, combined with our
yeast two-hybrid data showing that human Bub1fl does not
interact with Bub1(1–189) (Fig. 1D), suggests yeast Bub1
dimerization to be species-specific and/or a result of protein
truncation. Notably, the TPR domain of yeast Mad3 is mono-
meric. Thus, although the native oligomeric state of yeast Bub1
remains uncertain, dimerization of the Bub protein TPR
domain seems to be the exception rather than the rule.
Noncanonical Packing of the Bub Protein TPR Domain—To
further define the noncanonical features of the Bub protein
TPR domain, we looked at interactions occurring within a TPR
motif. Typical interactions of classical TPR domains involve
large hydrophobic residues packing against small hydrophobic
residues to create an angle of 6–20° between -helices (Fig. 5A)
(51). In the BubR1 TPR domain, such interactions are present
in TPR1 andTPR3 but not TPR2 (Fig. 5B). TPR1 has an angle of
11.9° between -helices as Trp78 and Thr85 pack against Ala105
and Met98 correspondingly, whereas TPR3 is somewhat
extreme and has an angle of 8.6° between -helices as Tyr155
and Tyr162 pack against Gly178 and Ala171 correspondingly.
TPR2 is distinct as pairing of medium sized Leu122 and Leu142,
and the presence of helix-truncating Pro135, induce an angle of
25.3° between-helices. This atypical packing is reflected in the
high backbone root mean square deviations between TPR2 and
TPR1 (2.67 Å2) or TPR3 (2.92 Å2) compared with that between
TPR1 and TPR3 (1.28 Å2). Like many TPR motifs, TPR1 and
TPR3 adopt similar conformations despite having less than 4%
sequence identity (Fig. 3A). This unique packingwithinTPR2 is
not likely a result of crystal packing as it is conserved in the yeast
Bub1 TPR domain structure where pairing of medium sized
Leu108 and Met133 similarly causes a 20° angle between the
-helices of TPR2 (Fig. 4B). Ultimately, this unique packing
within TPR2 causes it to have noncanonical interactions with
neighboring repeats.
The dominant interaction between neighboring repeats of a
TPR domain involves the stacking of large hydrophobic resi-
dues at TPR consensus positions 7 and 24 (51) (Fig. 5A). In the
BubR1 TPR domain, this interaction is observed between the
short N-terminal -helix and TPR1 (Tyr64–Tyr81), TPR2 and
TPR3 (Tyr139–Trp158), TPR3, and the C-terminal -helix
(Phe175–His193) but not between TPR1 and TPR2 (Fig. 5C).
Between TPR1 and TPR2, the canonical stacking of Leu102 and
Trp125 is replaced by salt bridges (Asp73–Arg120 and Glu86–
Lys127) and other hydrophobic packing interactions. The resi-
dues involved in these ionic interactions are either strictly con-
served (Asp73 and Arg120) or conserved in higher eukaryotic
Bub proteins (Glu86 and Lys127) (Fig. 3A). These noncanonical
interactions are of note as they cause -helix A of TPR2 to lie
across both-helices of TPR1 (Fig. 5C, panel ii). This ultimately
reduces the regularity of the super-helical twist and flattens the
concave surface which in a TPR domain is frequently a site of
protein interaction (57). Such peculiar packingmay be required
to accommodate the 310-helix between TPR1 and TPR2 as it is
also observed in the yeast Bub1 TPR domain, even though it is
achieved through alternative interactions (Fig. 4B). Impor-
FIGURE4.Comparisonof thehumanBubR1andyeastBub1TPRdomains.A, summary of theoutput from theDALI server. ProteinData Bank codes are 3ESL
(Bub1), 1A17 (PP5), and 1NA0 (engineered three-repeat TPR). Res., residues; r.m.s.d., root mean square deviation. B, superposition of the BubR1 (yellow) and
Bub1 (red) TPR domains. Shared features are labeled black, and different features are labeled yellow/red for BubR1/Bub1. The Blinkin-binding groove and
G(N/D)Dmotif are labeledgray.C, dimerization interface of the yeast Bub1 TPRdomain. Residues involved in salt bridge formation important for dimer stability
are shown as sticks and are lightly colored.D, electrostatic surface of the yeast Bub1 TPR domain dimerization interface (left) and the equivalent interface in the
human BubR1 TPR domain (right). The electrostatic surface (positive shown in blue, negative shown in red) was calculated using APBS in PyMOL.
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tantly, a flatter concave surface likely impacts the character of
this putative protein interaction site.
Identification of a Blinkin-binding Groove in the BubR1 TPR
Domain—A previous analysis of the interaction between hu-
man Bub1(1–189) and Blinkin(1–728) implicated the GIG and
G(N/D)D motifs of the Bub1 TPR domain (Fig. 4B) (39). The
conservation of these motifs in the BubR1 TPR domain
prompted us to test whether they are similarly involved in the
interaction between human BubR1(1–237) and Blinkin(1–
728). The GIG motif superimposes very well between the two
structures, although the conformation of the G(N/D)D motif
varies (Fig. 4B). Yeast two-hybrid analysis showed that the
BubR1-Blinkin interaction was unaffected by mutation of the
G(N/D)Dmotif (N72A/D73A), as well as by most mutations of
the GIG motif (G146N, G148N, and G146N/G148N).3 How-
ever, the BubR1-Blinkin interaction was abrogated by the GIG
mutant G146N/G148V. This is likely explained by the ability of
asparagine, but not valine, to adopt positive  angles observed
for the native glycine residues at these positions that appear
important for formation of the TPR domain structure (58).
Thus, the G(N/D)D and GIG motifs of BubR1 do not seem to
establish direct contacts with Blinkin. Nevertheless, the latter
motif is important for the structural integrity of the Blinkin-
binding site. Its location at the end of a groove on the surface of
BubR1 (Fig. 6C), formed by TPR2 and TPR3, raises the possi-
bility that this constitutes the Blinkin-binding region.
To test this, the importance of numerous residues exposed in
the BubR1 groove formed by TPR2 and TPR3 was examined.
Yeast two-hybrid analysis was performed using a series of
BubR1fl alanine mutants (P119A, L126A, R130A, S157A,
E161A, and R165A) fused to the GAL4 DNA-binding domain
and Blinkin(1–728) or Bub3fl fused to the GAL4 activator
domain (Fig. 6C). Although all BubR1fl mutants retained an
ability to bind Blinkin(1–728), BubR1fl mutants L126A, E161A,
and R165A experienced a highly reproducible reduction in the
rate of growth and number of colonies on SD/Ade/His/
Leu/Trp plates (selecting for the presence of both plasmids,
along withHIS andADE reported gene activation) and-galac-
tosidase activity (lacZ reporter gene activation) (Fig. 6A). This
was particularly noticeable when mated yeast were incubated
on selection plates for 2 or 3 days rather than 5 days. The rate of
yeast growth, the number of resultant colonies, and the rate and3 S. D’Arcy, T. Kiyomitsu, and V. Bolanos-Garcia, unpublished data.
FIGURE 5. BubR1 TPR domain exhibits both canonical and noncanonical packing interactions. A, TPR motif consensus sequence. B, interactions within
BubR1 TPRmotifs (panels i–iii) involving TPR consensus positions 4, 11, 8, 20, 24, and 27 (sticks). The angle between-helices is noted. Superposition of the TPR
motifs (panel iv) highlights the noncanonical packing of TPR2. C, packing between BubR1 TPR motifs (panels i–iv). Between TPR1 and TPR2, the canonical
hydrophobic stacking of TPR consensus positions 7 and 24 (sticks) is replaced by ionic interactions (dotted lines). For all images, the N-terminal-helix is yellow;
TPR1 is green; TPR2 is red; TPR3 is blue, and the C-terminal -helix iswhite.
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intensity of X-gal reaction are directly related to the underlying
level of reporter gene activation, which for constant GAL4
DNA-binding domain bait and GAL4 activation domain target
fusion proteins (modified by pointmutagenesis) provide “semi-
quantitative” assessment of binding affinities (41). Thus, our
observations indicate reduced levels of reporter gene activa-
FIGURE 6. Blinkin binds a groove formed by TPR2 and TPR3 of the BubR1 TPR domain. Time course (A) and high stringency (B) analysis of the interaction
between BubR1fl point mutants (wild type (WT), P119A, L126A, R130A, S157A, E161A, and E165A) and Blinkin(1–728) or Bub3fl is shown. Strains Y187(pGBT9-
BubR1fl) and AH109(pGAD424-Blinkin(1–728)) or Bub3fl were mated and X-gal filter lift assays performed on colonies grown on SD/Ade/His/Leu/Trp
plates for 2, 3, or 5 days in the presence of 0, 5, 10, or 15mM3-AT. Densitometry graphs represent the intensity of eachmating condition relative to the intensity
of wild type BubR1fl following 5 days of growthwith 0mM3-AT. C, schematic (left) and surface (right) representation of the BubR1 TPR domain highlighting the
residues involved in Blinkin binding (orange, residues not involved arewhite). The GIG motif (yellow) is not surface-exposed.
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tion, and hence reduced binding affinity, for BubR1fl mutants
L126A, E161A, and R165A. Importantly, for all BubR1fl
mutants, the growth of mated yeast on SD/Leu/Trp plates
(selecting for the presence of both plasmids) was unaffected,
and a wild type level of interaction with Bub3fl was detected at
all time points (Fig. 6A). These observations exclude the possi-
bility of the mutants affecting the growth characteristics of the
yeast, fusion protein expression levels, or fusion protein stabil-
ity. Instead, these data are consistent with the L126A, E161A,
and R165A BubR1mutants reducing the affinity of the interac-
tion between BubR1fl and Blinkin(1–728).
To confirm the involvement of BubR1 residues Leu126,
Glu161, andArg165 in Blinkin(1–728) binding,mated yeast were
selected on SD/Ade/His/Leu/Trp plates containing
3-AT, a competitive inhibitor of the HIS3 reporter gene prod-
uct frequently used to eliminate background levels of reporter
gene activation. Upon testing the interaction with Blinkin(1–
728), the growth of colonies for BubR1fl mutants L126A,
E161A, and R165A was almost completely eliminated by 5 mM
3-AT (Fig. 6B). This is in contrast to the growth of colonies for
wild type BubR1fl and mutants P119A, R130A, and S157A,
which were only mildly affected. Increasing 3-AT to 10 or 15
mM had little additional effect on BubR1fl mutants L126A,
E151A, and R165A, while furthering the mild inhibition of
wild type BubR1fl and mutants P119A, R130A, and S157A
(Fig. 6B). The interactions between all BubR1fl mutants and
Bub3fl were equally unaffected by the presence of 5–15 mM
3-AT, consistent with a Bub3-binding site downstream of
the BubR1 TPR domain (36, 37). We therefore conclude that
the affinity of the BubR1fl-Blinkin(1–728) interaction is sub-
stantially reduced by BubR1 mutations L126A, E161A, and
R165A and is unaffected by the BubR1 mutations P119A,
R130A, and S157A. The yeast two-hybrid data presented
here thus demonstrate that side chains of Leu126, Glu161, and
Arg165 contribute to the Blinkin-binding interface of the
BubR1 TPR domain. These residues belong to a shallow
groove on the inner concave surface of the BubR1 domain
defined by TPR2 and TPR3 (Fig. 6C). Although each individ-
ual residue is not essential for the interaction, mutation
results in a reduction in binding affinity. This could be char-
acteristic of a “Velcro-like” mode of interaction where mul-
tiple discrete and potentially cooperative interfaces contrib-
ute to the overall protein-protein interaction.
DISCUSSION
Distinct roles have been described for BubR1 in its enrich-
ment at kinetochores incorrectly/not attached to the mitotic
spindle and as a constituent of the MCC, which inhibits APC/
C-Cdc20 ubiquitin ligase activity. The mechanistic links
between these cellular pools of BubR1 and their contribution to
the SAC, however, remain unknown. Such understanding
requires detailed molecular information regarding BubR1 and
the basis of its interactions both at the kinetochore and within
the MCC. Thus far, this has not been possible as recombinant
protein instability has hampered high resolution structural
analysis of BubR1 or its paralogueMad3 (35, 36). Here, we have
overcome this difficulty and, through detailed mapping of the
molecular architecture of the functionally significant N-termi-
nal portion of human BubR1, have solved the crystal structure
of its TPR domain at 1.8 Å resolution. The structure reveals
subtle but significant deviations from a canonical TPR
domain that likely provide protein-specific functionality.
Such deviations are shared with the yeast Bub1 TPR domain
and thus define a common structural scaffold of Bub pro-
teins. Key distinctive features include the disordered loop
insertion of TPR1, the insertion of a 310-helix between TPR2
and TPR3, the tight turn involving positive angles between
TPR2 and TPR3, and the noncanonical packing of and
between TPR motifs.
Analysis based on the BubR1 structure also facilitated novel
molecular insight into BubR1 interactions at the kinetochore.
We confirmed the interaction between BubR1(1–237) and
Blinkin(1–728) using a yeast two-hybrid assay and defined the
molecular determinants of this interaction through structure-
directedmutagenesis. This revealed a series of residues, Leu126,
Glu161, andArg165, locatedwithin a shallow groove on the inner
concave surface of the BubR1TPR domain that each contribute
to the Blinkin interaction. The significant reduction, but not
elimination, of the Blinkin interaction upon individual muta-
tion of these residues, and the discrete distribution of these
residues within the groove, suggests the interaction ismediated
by a number of potentially cooperative interfaces. This binding
groove is subtly distinct from that of other TPR domains as the
unusual packing of TPR2 means it is formed by the A -helices
of TPR2 and TPR3 but not TPR1.3 Canonical TPR domains
typically contain a binding pocket formed by all three A -heli-
ces on the inner concave surface (57). The overall polarity of
this groove and the importance of residues Glu161 and Arg165
suggest a role for ionic contacts in mediating the Blinkin inter-
action, possibly compensating for relatively weak hydrophobic
packing associated with the shallowness of the groove. The
Blinkin-binding groove of the BubR1 TPR domain thus differs
fromprevious characterized TPR domains and likely provides a
unique functionality.
A complementary aspect of BubR1 function is Bub1-depen-
dent kinetochore enrichment (29, 32). Our data reveal a physi-
cal interaction between BubR1 and Bub1 that is mediated by
regions downstream of their TPR domains. Both BubR1 and
Bub1 undergo direct interactions with Blinkin via their TPR
domains,with their respective “Blinkin-binding” grooves show-
ing gross structural similarity. However, specific differences are
predicted as Glu161 and Arg165 are not conserved in Bub1, and
theG(N/D)Dmotifmay be differentially required (39), suggest-
ing that the BubR1 and Bub1TPR domainsmay bind to distinct
regions within Blinkin. This is supported by the finding that
although BubR1 binding is restricted to the N-terminal region
of Blinkin, Bub1 also interacts with the central region of Blinkin
(32). Futurework is clearly required to define the precise nature
of these interactions. Nevertheless, this combination raises the
possibility of a ternary complex between BubR1, Bub1, and
Blinkin at kinetochores; their orderly assemblymay be essential
for SAC activation.
The molecular architecture of the larger BubR1 N-terminal
region provides further insight into its role in APC/C-Cdc20
inhibition as part of theMCC. Specifically, the first KEN box of
BubR1 is located within the flexible N-terminal extension that
Structure of the BubR1 N-terminal Domain
14774 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 19•MAY 7, 2010
 at N
ew
castle U
niversity on M
arch 20, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
protrudes from the TPR domain. APC/C-Cdc20 recognition of
the KEN box in this location may thus be affected by a recently
reported phosphorylation event at Thr54, which lies at the
boundary between the N-terminal extension and the TPR
domain (59). In addition to BubR1 KEN boxes, APC/C-Cdc20
inhibition may also depend on interactions between the BubR1
TPR domain and other APC/C components. This is supported
by a recent electron microscopy structure of the human APC-
C-MCC complex, which reveals that the MCC, and in particu-
lar BubR1, is located in close proximity to APC/C TPR protein
APC5 (21).
On the basis of findings reported here and in previous stud-
ies, we present a model for BubR1 SAC function (Fig. 7). First,
BubR1 is recruited to kinetochores incorrectly/not attached to
the mitotic spindle through a direct
interaction with Bub1. A ternary
complex of BubR1, Bub1, and
Blinkin is thus formed (32). The
TPR domains of BubR1 and Bub1
each bind Blinkin, although their
C-terminal regionsmediate interac-
tions with each other andwith Bub3
(36, 37). This complex is predicted
to sustain the SAC, with the kinase
activity and/or phosphorylation of
BubR1 triggering prolonged mitotic
arrest (23). Second, BubR1 inhibits
APC/C-Cdc20 ubiquitin ligase
activity as part of the MCC (16).
This is achieved through direct
interactions between BubR1 KEN
boxes and APC/C-Cdc20 (24), and
possibly additional interactions
between the BubR1 TPR domain
and APC/C subunits. A potential
mechanismbywhichBubR1 kineto-
chore enrichment induces pro-
longedAPC/C-Cdc20 inhibition is a
signal cascade inwhich downstream
targets include enzymes that post-
translationally modify BubR1, other
MCC components, or APC/C-
Cdc20, thus affecting APC/C-
Cdc20 ubiquitin ligase activity.
Although details of SAC silencing
remain to be elucidated (60), one
redundant mechanism may involve
inhibition of BubR1 kinase activity
byCENP-E, uponCENP-Emicrotu-
bule capture (31). However, these
models have not yet been tested
within the cellular context. The
detailed molecular understanding
of the BubR1 N-terminal domain
provided by this study will now
permit such an analysis to be
performed; structure-directed engi-
neering of BubR1 will for the first
time allow its distinct roles in kinetochore recruitment and
APC/C-Cdc20 inhibition to be dissected in vivo.
Acknowledgments—We thank L. Packman for mass spectrometry
analysis;M.Weldon for Edmandegradation;M.Hyvo¨nen for reagents
and advice; G. Grossman for assistance with small angle x-ray scat-
tering; M. Moncrieffe for assistance with analytical ultracentrifuga-
tion; B. Luisi for advice on phasing; T. Kiyomitsu andM. Yanagida for
initial yeast two-hybrid experiments; and S. Lowell for support.
REFERENCES
1. Zich, J., and Hardwick, K. G. (2010) Trends Biochem. Sci. 35, 18–27
2. Kops, G. J. (2008) Front. Biosci. 13, 3606–3620
3. Thornton, B. R., and Toczyski, D. P. (2003) Nat. Cell Biol. 5, 1090–1094
FIGURE 7.BubR1 exerts a SAC function through interactionwith numerous protein ligands. The N-termi-
nal regionof BubR1mediates interactionswithBlinkin, Cdc20, andpossibly theAPC/C, although theC-terminal
region forms contacts with Bub3, Bub1, and CENP-E.
Structure of the BubR1 N-terminal Domain
MAY 7, 2010•VOLUME 285•NUMBER 19 JOURNAL OF BIOLOGICAL CHEMISTRY 14775
 at N
ew
castle U
niversity on M
arch 20, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
4. Uhlmann, F., Wernic, D., Poupart, M. A., Koonin, E. V., and Nasmyth, K.
(2000) Cell 103, 375–386
5. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz,
S. D., Kinzler, K. W., and Vogelstein, B. (1998) Nature 392, 300–303
6. Logarinho, E., and Bousbaa, H. (2008) Cell Cycle 7, 1763–1768
7. Weaver, B. A., and Cleveland, D. W. (2006) Curr. Opin. Cell Biol. 18,
658–667
8. Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., Fitzpatrick, D., Kidd,
A., Me´hes, K., Nash, R., Robin, N., Shannon, N., Tolmie, J., Swansbury, J.,
Irrthum, A., Douglas, J., and Rahman, N. (2004) Nat. Genet. 36,
1159–1161
9. Matsuura, S., Matsumoto, Y., Morishima, K., Izumi, H., Matsumoto, H.,
Ito, E., Tsutsui, K., Kobayashi, J., Tauchi,H., Kajiwara, Y., Hama, S., Kurisu,
K., Tahara, H., Oshimura,M., Komatsu, K., Ikeuchi, T., andKajii, T. (2006)
Am. J. Med. Genet. A 140, 358–367
10. Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., and
van Deursen, J. M. (2003) J. Cell Biol. 160, 341–353
11. Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S.,
Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., and van
Deursen, J. M. (2004) Nat. Genet. 36, 744–749
12. Dai, W., Wang, Q., Liu, T., Swamy, M., Fang, Y., Xie, S., Mahmood, R.,
Yang, Y. M., Xu, M., and Rao, C. V. (2004) Cancer Res. 64, 440–445
13. Rao, C. V., Yang, Y. M., Swamy, M. V., Liu, T., Fang, Y., Mahmood, R.,
Jhanwar-Uniyal, M., and Dai, W. (2005) Proc. Natl. Acad. Sci. U.S.A. 102,
4365–4370
14. Royou, A., Gagou, M. E., Karess, R., and Sullivan, W. (2010) Cell 140,
235–245
15. Homer, H., Gui, L., and Carroll, J. (2009) Science 326, 991–994
16. Sudakin, V., Chan, G. K., and Yen, T. J. (2001) J. Cell Biol. 154, 925–936
17. Pfleger, C. M., and Kirschner, M. W. (2000) Genes Dev. 14, 655–665
18. Fang, G. (2002)Mol. Biol. Cell 13, 755–766
19. Kulukian, A., Han, J. S., and Cleveland, D.W. (2009)Dev. Cell 16, 105–117
20. Davenport, J., Harris, L. D., and Goorha, R. (2006) Exp. Cell Res. 312,
1831–1842
21. Herzog, F., Primorac, I., Dube, P., Lenart, P., Sander, B., Mechtler, K.,
Stark, H., and Peters, J. M. (2009) Science 323, 1477–1481
22. Nilsson, J., Yekezare,M.,Minshull, J., and Pines, J. (2008)Nat. Cell Biol.10,
1411–1420
23. Malureanu, L. A., Jeganathan, K. B., Hamada, M., Wasilewski, L., Daven-
port, J., and van Deursen, J. M. (2009) Dev. Cell 16, 118–131
24. Burton, J. L., and Solomon, M. J. (2007) Genes Dev. 21, 655–667
25. Choi, E., Choe, H., Min, J., Choi, J. Y., Kim, J., and Lee, H. (2009) EMBO J.
28, 2077–2089
26. Howell, B. J., Moree, B., Farrar, E. M., Stewart, S., Fang, G., and Salmon,
E. D. (2004) Curr. Biol. 14, 953–964
27. Cheeseman, I. M., and Desai, A. (2008) Nat. Rev. Mol. Cell Biol. 9, 33–46
28. Millband, D. N., and Hardwick, K. G. (2002) Mol. Cell. Biol. 22,
2728–2742
29. Johnson, V. L., Scott, M. I., Holt, S. V., Hussein, D., and Taylor, S. S. (2004)
J. Cell Sci. 117, 1577–1589
30. Mao, Y., Desai, A., and Cleveland, D. W. (2005) J. Cell Biol. 170, 873–880
31. Mao, Y., Abrieu, A., and Cleveland, D. W. (2003) Cell 114, 87–98
32. Kiyomitsu, T., Obuse, C., and Yanagida, M. (2007) Dev. Cell 13, 663–676
33. Cheeseman, I. M., Chappie, J. S., Wilson-Kubalek, E. M., and Desai, A.
(2006) Cell 127, 983–997
34. Elowe, S., Dulla, K., Uldschmid, A., Li, X., Dou, Z., and Nigg, E. A. (2010)
J. Cell Sci. 123, 84–94
35. Yoon, J., Kang, Y., Kim, K., Park, J., and Kim, Y. (2005) Protein Expr. Purif.
44, 1–9
36. Larsen, N. A., Al-Bassam, J., Wei, R. R., and Harrison, S. C. (2007) Proc.
Natl. Acad. Sci. U.S.A. 104, 1201–1206
37. Wang, X., Babu, J. R., Harden, J. M., Jablonski, S. A., Gazi, M. H., Lingle,
W. L., de Groen, P. C., Yen, T. J., and van Deursen, J. M. (2001) J. Biol.
Chem. 276, 26559–26567
38. Hardwick, K. G., Johnston, R. C., Smith, D. L., and Murray, A. W. (2000)
J. Cell Biol. 148, 871–882
39. Bolanos-Garcia, V. M., Kiyomitsu, T., D’Arcy, S., Chirgadze, D. Y., Gross-
mann, J. G., Matak-Vinkovic, D., Venkitaraman, A. R., Yanagida, M., Rob-
inson, C. V., and Blundell, T. L. (2009) Structure 17, 105–116
40. Bolanos-Garcia, V. M., Beaufils, S., Renault, A., Grossmann, J. G., Brewer-
ton, S., Lee,M., Venkitaraman, A., and Blundell, T. L. (2005)Biophys. J. 89,
2640–2649
41. MacDonald, P. N. (2001)Methods Mol. Biol. 177, v–viii
42. Pera¨nen, J., Rikkonen, M., Hyvo¨nen, M., and Ka¨a¨ria¨inen, L. (1996) Anal.
Biochem. 236, 371–373
43. Collaborative Computational Project No. 4 (CCP4) (1994) Acta Crystal-
logr. D Biol. Crystallogr. 50, 760–763
44. Leslie, A. G. (2006) Acta Crystallogr. D Biol. Crystallogr. 62, 48–57
45. Vonrhein, C., Blanc, E., Roversi, P., and Bricogne, G. (2007)Methods Mol.
Biol. 364, 215–230
46. Perrakis, A., Sixma, T. K., Wilson, K. S., and Lamzin, V. S. (1997) Acta
Crystallogr. D Biol. Crystallogr. 53, 448–455
47. Emsley, P., and Cowtan, K. (2004)Acta Crystallogr. D Biol. Crystallogr. 60,
2126–2132
48. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997)Acta Crystallogr.
D Biol. Crystallogr. 53, 240–255
49. Painter, J., and Merritt, E. A. (2006) Acta Crystallogr. D Biol. Crystallogr.
62, 439–450
50. D’Andrea, L. D., and Regan, L. (2003) Trends Biochem. Sci. 28, 655–662
51. Main, E. R., Xiong, Y., Cocco, M. J., D’Andrea, L., and Regan, L. (2003)
Structure 11, 497–508
52. Sikorski, R. S., Boguski, M. S., Goebl, M., and Hieter, P. (1990) Cell 60,
307–317
53. Das, A. K., Cohen, P. W., and Barford, D. (1998) EMBO J. 17, 1192–1199
54. Yang, J., Roe, S.M., Cliff,M. J.,Williams,M.A., Ladbury, J. E., Cohen, P. T.,
and Barford, D. (2005) EMBO J. 24, 1–10
55. Holm, L., Ka¨a¨ria¨inen, S., Rosenstro¨m, P., and Schenkel, A. (2008) Bioin-
formatics 24, 2780–2781
56. Rice, L. M., and Brunger, A. T. (1999)Mol. Cell 4, 85–95
57. Cliff, M. J., Harris, R., Barford, D., Ladbury, J. E., and Williams, M. A.
(2006) Structure 14, 415–426
58. Deane, C. M., Allen, F. H., Taylor, R., and Blundell, T. L. (1999) Protein
Eng. 12, 1025–1028
59. Imami, K., Sugiyama, N., Kyono, Y., Tomita, M., and Ishihama, Y. (2008)
Anal. Sci. 24, 161–166
60. Vanoosthuyse, V., and Hardwick, K. G. (2009)Genes Dev. 23, 2799–2805
Structure of the BubR1 N-terminal Domain
14776 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 19•MAY 7, 2010
 at N
ew
castle U
niversity on M
arch 20, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
